Lifordi Immunotherapeutics
Developer of targeted antibody-drug conjugates (ADCs) designed to treat autoimmune and inflammatory disorders. The company offers a proprietary ADC platform demonstrating enhanced efficacy and safety ...
Valuation
$0
Share Price
N/A
Total Raised
$112M
Last Round
N/A